Samsung Biologics Pushes Up Timeline of New Plant

June 13, 2023

Article

CDMO’s new facility is expected to be operational by April 2025.

Licensed FILE #: 255151062 Preview Crop Find Similar DIMENSIONS 6016 x 4016px FILE TYPE JPEG CATEGORY Industry LICENSE TYPE Standard or Extended Verfahrenstechnik in einem Chemiewerk: Rohrleitungen und anlage in der Pharamindustrie //Process engineering in a chemical plant: Pipelines and equipment in the pharam industry. Image Credit: Adobe Stock Images/industrie/blink

Samsung Biologics, a contract development and manufacturing organization (CDMO) plans to have its new fifth plant operational by April 2025. Earlier this month, the company fully completed its latest biomanufacturing plant, Plant 4.

As the first facility of Samsung Biologics’ second Bio Campus at its headquarters in Songdo, South Korea, Plant 5 is expected to have a construction timeline of 24 months. It will add a capacity of 180,000 liters, featuring process integration and optimization, as well as advanced automation. The new plant will also feature sustainable systems to support the company’s commitment in achieving net zero greenhouse gas emissions by 2050 or earlier.

Related Content

Fujifilm Completes Cell Therapy Plant Expansion Project

Nicholas Saraceno, Editor

November 21st 2024

Article

The CDMO's California facility welcomes new production suites, a revamp of its development labs, and more.

Pii Invests in Prefilled Syringe Capabilities

Nicholas Saraceno, Editor

November 19th 2024

Article

The CDMO is investing $3.6 million toward boosting its advanced labeling, automated visual inspection, and fill-finish tech.

Why Pharmaceutical Products Need Sustainable Packaging

Bradley Dunlap

November 8th 2024

Article

One packaging aspect—the tape—is often overlooked, but is a valuable component of the shipping process.

Rentschler Biopharma to Construct New Buffer Media Facility in Germany

Nicholas Saraceno, Editor

October 28th 2024

Article

With the design of the new 360,000 square-foot building, the CDMO’s goal is to continue to modernize its Laupheim site.

BD, ten23 health to Roll Out Prefillable Syringes with RFID Capabilities

Nicholas Saraceno, Editor

October 8th 2024

Article

With the implementation of unit-level traceability, the collaboration is expected to provide additional visibility not only within the aseptic manufacturing process, but the entire supply chain overall.